| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.64 | 4e-06 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.61 | 0.0001 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |